Breast Cancer and Chemo-amennorhea

NCT ID: NCT01867229

Last Updated: 2019-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-10-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Relation between chemotherapy and amennorhea

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FEC- TC

Fluorouracil- Epiadriamycine- Cyclophosphamide Taxotère-Cyclophosphamide

observational

Intervention Type OTHER

standard of care fore patients with non metastatic breast cancer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observational

standard of care fore patients with non metastatic breast cancer

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

pre-menauposal breast cancer needed to be treat with chemotherapy -

Exclusion Criteria

metastases menopausal

\-
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

jean-Pascal Machiels

Role: PRINCIPAL_INVESTIGATOR

UCL-Saint Luc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Saint Vincent

Rocourt, Liège, Belgium

Site Status

Cliniques Universitaires Saint-Luc

Brussels, , Belgium

Site Status

Centre Hospitalier Université de Liège

Liège, , Belgium

Site Status

CHR Citadelle

Liège, , Belgium

Site Status

Centre hospitalier Peltzer La Tourelle

Verviers, , Belgium

Site Status

Institut Claudius Renaud

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2009/07DEC/377

Identifier Type: OTHER

Identifier Source: secondary_id

UCL-gyneco-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.